Previous 10 | Next 10 |
Abiomed, Inc . (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that it will host a Virtual Investor Day covering Clinical Data & Innovation on May 27, 2020 from 8:30 a.m. – 12:00 p.m. EDT. The event will include presentations from memb...
Women Disproportionately Impacted with Bailout Data from more than 1,000 patients presented during the virtual 2020 Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions demonstrates Impella reduced in-hospital mortality when placed before a non-emerge...
Abiomed (NASDAQ: ABMD) , the first company to implant a totally artificial heart in a patient back in 2001, develops technology to help hearts recover. The company's main products are the world's smallest heart pump, the Impella, and its supporting SmartAssist technology. Abiomed's share pri...
Medical device maker Abiomed (NASDAQ: ABMD) saw a high last week of $197.75 per share. The stock closed at $191.25 on Thursday, an improvement of 13% over Wednesday's closing price. Even after some slippage on Friday and Monday, the stock is still trading roughly $17 a share higher than it w...
Abiomed, Inc. (ABMD) Q4 2020 Earnings Conference Call April 30, 2020 08:00 ET Company Participants Todd Trapp - VP & CFO Michael Minogue - Chairman, President & CEO Seth Bilazarian - Chief Medical Officer Conference Call Participants Margaret Kaczor - William Blair ...
Image source: The Motley Fool. Abiomed Inc (NASDAQ: ABMD) Q4 2020 Earnings Call Apr 30, 2020 , 8:00 a.m. ET Operator Continue reading
Shares of Abiomed (NASDAQ: ABMD) , a maker of medical devices that improve heart function, soared after the company announced the acquisition of a company that has developed a portable artificial lung and also reported better-than-expected earnings for its fiscal fourth quarter. In addition, ...
Abiomed ( ABMD +15.3% ) is enjoying its largest intraday gain in almost five years after posting fiscal Q4 results this morning that dampened fears that the quarter would be much worse that it was due to COVID-19 disruptions on non-life-saving procedures. More news on: Abiomed, Inc., H...
The following slide deck was published by Abiomed, Inc. in conjunction with their 2020 Q4 earnings Read more ...
Abiomed ( ABMD ) Q4 results : More news on: Abiomed, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...